Aude Maurousset
Tours, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Kappa free light chain index or oligoclonal bands testing in clinical practice for multiple sclerosis diagnosis: An algorithm comparative study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 06, 2026
Outcome Predictors in Progressive Multifocal Leukoencephalopathy Associated With Multiple Sclerosis Treatments: A Multicenter Cohort Study.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 20, 2026
Presentation and Outcome in S1P-RM and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: A Multicenter Cohort Study.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 11, 2024
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: January 22, 2024
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.
Journal: JAMA network open
Published: June 23, 2023
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 14, 2022
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 17, 2022
Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: April 07, 2022
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: February 07, 2022
Last Updated: 09/26/2026